References
- Agnusdei, D., Zucchei, F., Bigazzi, S., Cepellaro, C., Nardi, P., Montignani, M., and Gennari, C., Metabolic and clinical effects of ipriflavone in etablished post-menopausal osteoporosis. Drugs Exptl. Clin. Res., 15, 97-104 (1989)
- Androanarivo, A. G., Robinson, J. A., Mann, K. G., and Tracy, R. P., Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell Physiol., 153, 256-265 (1992) https://doi.org/10.1002/jcp.1041530205
- Bergkvist, L., Admi, H. O., Persson, I., Hoover, R., and Schairer, C., The risk of breast cancer after estrogen and estrogenprogestin replacement. N. Engl. J. Med., 321, 293-297 (1989) https://doi.org/10.1056/NEJM198908033210505
- Bryant, H. U. and Dere, W. H., Selective estrogen receptor modultors: an alternative to hormone replacement therapy. Proc. Soc. Exp. Bio. Med., 217, 45-52 (1998) https://doi.org/10.3181/00379727-217-44204
- Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B., Evaluation of a tetrazolium-based semiauto-mated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47, 936-942 (1987)
- Ederveen, A. G. H., Spanjers, C. P. M., Quaijtaal, J. H. M., and Kloosterboer, H. J., Effect of 16 Months of Treatment with Tibolone on Bone Mass, Turnover, and Biomechanical Quality in Mature Ovariectomized Rats. J. Bone Miner. Res., 16, 1674-1681 (2001) https://doi.org/10.1359/jbmr.2001.16.9.1674
- Gillespy, T., 3rd and Gillespy, M. P., Osteoporosis. Radiol. Clin. North America, 29, 77-84 (1991)
- Kassem, M., Mosekilde, L., and Eriksen, E. F., 1,25-Dihydroxy-vitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. J. Bone Miner. Res., 8, 1453-1458 (1993) https://doi.org/10.1002/jbmr.5650081207
- Kassem, M., Mosekilde, L., and Eriksen, E. F., Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts. Eur. J. Endocrinol., 130, 381-386 (1994) https://doi.org/10.1530/eje.0.1300381
- Kim, C., Kim, J. S., Kim, Y. T., and Song, K. Y., Effects of herbal medicine on tibia bone changes in ovariectomized rats and SAM P6 mice. Yakhak Hoeji, 42, 220-228 (1998)
- Kim, C., Kim, J. S., Kim, Y. T., and Song, K. Y., Korean Patent No. 0284657 (2000)
- Kim, C., Ha, H., and Song, K. Y., A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives. WO patent # PCT/KR01/00368 (2001. 3. 9.)
- Kim, C., Ha, H., Kim, J. S., Kim, Y. T., Kwon, S. C., and Park, S. W., Induction of growth hormone by the roots of Astragalus membranaceus in pituitary cell culture. Arch. Pharm. Res., 26, 34-39 (2003) https://doi.org/10.1007/BF03179928
- Kobayashi, T., Sekine, S., Maekawa, Y., Suzuki, H., Shimoda, Z., and Ono, I., Foodsuffs and pharmaceuticals. European Patent # 0104043 (1983. 09. 14)
- Koh, E. T., Torabinejad, M. P., Ford, T. R., Brady, K., and McDonald, F., Mineral trioxide aggregate stimulates a biological response in human. J. Biomed. Mater. Res., 37, 432-439 (1997) https://doi.org/10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
- Lark, M. W., Stroup, G. B., Dodds, R. A., Kapadia, R., Hoffman, S. J., Hwang, S. M., James, I. E., Lechowska, B, Liang, X., Rieman, D. J., Salyers, K. L., Ward, K., Smith, B. R., Miller, W. H., Huffman, W. F., and Gowen, M., Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovariectomized Rat. J. Bone Miner. Res., 16, 319-327 (2001) https://doi.org/10.1359/jbmr.2001.16.2.319
- Nordin, B. E., Heyburn, P. J., and Peacock, M., Osteoporosis and osteomalacia. Clin. Metab., 9, 177-205 (1980) https://doi.org/10.1016/S0300-595X(80)80026-0
- Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., and Recker, R. R., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res., 2, 595-610 (1987) https://doi.org/10.1002/jbmr.5650020617
- Ragab, A. A., Lanvish, S. A., Banks, M. A., Goldgerg, V. M., and Greenfiled, E. M., Osteoclast differentiation requires ascorbic acid. J. Bone Miner. Res., 13, 970-977 (1998) https://doi.org/10.1359/jbmr.1998.13.6.970
- Rosner, B., Fundamentals of biostatistics. PWS-Kent Co., Boston, MA, USA, (1990)
- Sabokbar, A., Millett, P. J., Myer, B., and Rushton, N., A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner., 27, 57-67(1994) https://doi.org/10.1016/S0169-6009(08)80187-0
- Shin, G. K., Shins Herbalogy: Sumoon-sa, Seoul, Korea, (1988)
- Shioi, A., Ross, F. P., and Teitelbaum, S. L., Enrichment of generated murine osteoclasts. Calcif. Tissue Int., 55, 387-394 (1994) https://doi.org/10.1007/BF00299320
- Takada, Y., Kusuda, M., Hiura, K., Sato, T., Mochizuki, H., Nagao, Y., Tomura, M., Yahiro, M., Hakeda, Y., Kawashima, H., and Kumegawa, M., A simple method to assess osteocalst-mediated bone resorption using unfractionated bone cells. Bone Miner., 17, 347-359 (1992) https://doi.org/10.1016/0169-6009(92)90785-C
- Wark, J. D., Osteoporotic fractures: background and prevention strategies. Maturitas, 23, 193-207 (1996) https://doi.org/10.1016/0378-5122(95)00974-4
- Whitehead, M. I. and Fraser, D., Controversies concerning the safety of estrogen replacement therapy. Am. J. Obstet. Gynecol., 156, 1313-1322 (1987) https://doi.org/10.1016/0002-9378(87)90170-0
- Yang, Y. M., Hyun, W., Lim, H., Sung, M. S., Kang, S. S., Paik, W. H., Bae, K. W., Cho, H., Kim, H. J., Woo, E. R., Park, H., and Park, J. G., Antineoplastic effects of extracts from traditional medicinal plants and various plants (III). Kor. J. Pharmacogn., 27, 105-110 (1996)
- Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. Bone, 27, 761-764 (2000) https://doi.org/10.1016/S8756-3282(00)00420-8